drug development strategiespreclinical development programtherapeutic biologicsThere are a variety of considerations unique to biologics development owing to the inherent differences in their properties and characteristics. These differences dictate different approaches to both preclinical and clinical development, ...
The requirement for delivery by injection is currently a limitation for the use of biologic drugs such as antibodies. In this Review, Mitragotri and colleagues discuss advances made in non-invasive drug delivery for biologics, including the transdermal,
Cell line development is the use of various techniques to optimize a cell line for the production of a stable target biotherapeutic in high yield. Not taking the time to implement a robust cell line development process can lead to difficulties down the manufacturing pipeline, which wast...
The 9th annual event returns to Boston in 2024, continuing to support drug developers of all sizes in advancing their novel biotherapeutics discovery and development, join us!
By implementing effective risk assessment strategies and working with reliable, selected solution providers, biopharmaceutical manufacturers can minimize these challenges and improve product quality. Considering Process Scaling for Monoclonal Antibodies During Early Phase Development Cynthia A. Challener August ...
and processes. Biopharma is catching up to other industries that have been using digital twins for some time to create in silico representations that provide powerful predictive capabilities. In biopharma, we want to move increasingly toward a place where phases of drug d...
Why Abzena? We are advocates and partners for your success. We deploy the best biologic development technologies, shorten lead times, and implement effective risk mitigation strategies. Discover Testimonials Latest Insights News: Expansion of Analytical Capabilities ...
Advent of Innovative Drug Delivery Systems has Also Unfolded Many Novel Opportunities In addition, a number of device manufacturers have emerged with their novel drug delivery systems that facilitate subcutaneous administration; we identified over 200 such systems. ...
BioDuro has built up comprehensive antibody discovery capabilities with differentiation from current market offerings. Multiple technologies are established to discover antibodies from all kinds of antibody gene sources. We use creative strategies to overcome the pain points of the therapeutic antibody discov...
“Well-orchestrated and integrated device, packaging, and labeling strategies can succeed on all [these fronts] if planned and executed synchronously,” explains Schroeder. A customizable on-body delivery system, the Vertiva platform developed by Stevanato and Thermo Fisher Scientific, consists of a ...